| Literature DB >> 23663086 |
Carlos Huerta1, Nick V Grishin, Hong Zhang.
Abstract
FMN adenylyltransferase (FMNAT) is an essential enzyme catalyzing the last step of a two-step pathway converting riboflavin (vitamin B2) to FAD, the ubiquitous flavocoenzyme. A structure-based mutagenesis and steady-state kinetic analysis of yeast FMNAT unexpectedly revealed that mutant D181A had a much faster turnover rate than the wild-type enzyme. Product inhibition analysis showed that wild-type FMNAT is strongly inhibited by FAD, whereas the D181A mutant has an attenuated product inhibition. These results provide a structural basis for the product inhibition of the enzyme and suggest that product release may be the rate-limiting step of the reaction.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23663086 PMCID: PMC3795796 DOI: 10.1021/bi400454w
Source DB: PubMed Journal: Biochemistry ISSN: 0006-2960 Impact factor: 3.162